Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)

2 references·16 citing·41 second hop

FromToDepth

this work references cited by second hop

References

1975Book Review: Measurement and Classification of Psychiatric Symptoms2,262 cited
1992Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.268 cited

Cited by

19993,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans178 cited
1995Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations175 cited
2000The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers144 cited
2000Is MDMA (‘Ecstasy’) Neurotoxic in Humans? An Overview of Evidence and of Methodological Problems in Research142 cited
2006Ecstasy: Are animal data consistent between species and can they translate to humans?126 cited
1996Adverse Reactions with 3,4-Methylenedioxymethamphetamine (MDMA; ???Ecstasy???)123 cited
2001Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms120 cited
1999Cerebral 1H MRS alterations in recreational 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) users110 cited
2004Mood disorders and serotonin transporter density in ecstasy users—the influence of long-term abstention, dose, and gender108 cited
2004Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

105 cited

2002Long-Term Neuropsychiatric Consequences of "Ecstasy" (MDMA): A Review102 cited

2017The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review99 cited

2000High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users97 cited

1999The distribution of 3,4-methylenedioxymethamphetamine “Ecstasy”-induced c-fos expression in rat brain95 cited

2001A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field92 cited

2010Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire92 cited